Literature DB >> 25124613

Effect of lymphangiogenesis and lymphovascular invasion on the survival pattern of breast cancer patients.

Pradyumna Kumar Sahoo1, Debarshi Jana, Palash Kumar Mandal, Samindranath Basak.   

Abstract

BACKGROUND: Invasion of breast cancer cells into blood and lymphatic vessels is one of the most important steps for metastasis. In this study the prognostic relevance of lymphangiogenesis and lymphovascular invasion (LVI) in breast cancer patients was evaluated in terms of survival.
MATERIALS AND METHODS: This retrospective study concerned 518 breast cancer patients who were treated at Department of Surgical Oncology, Saroj Gupta Cancer Centre and Research Institute, Kolkata-700063, West Bengal, India, a reputed cancer centre and research institute of eastern India between January 2006 and December 2007.
RESULTS: The median overall survival and disease free survival of the patients were 60 months and 54 months respectively. As per Log-rank test, poor overall as well as disease free survival pattern was observed for LVI positive patients as compared with LVI negative patients (p<0.01). Also poor overall as well as disease free survival pattern was observed for perineural invasion (PNI) positive patients as compared to PNI negative patients (p<0.01).
CONCLUSIONS: From this study it is evident that LVI and PNI are strongly associated with outcome in terms of disease free as well as overall survival in breast cancer patients. Thus LVI and PNI constitute potential targets for treatment of breast cancer patients. We advocate incorporating their status into breast cancer staging systems.

Entities:  

Mesh:

Year:  2014        PMID: 25124613     DOI: 10.7314/apjcp.2014.15.15.6287

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma.

Authors:  Ricardo Vitor Silva de Almeida; Adhemar Monteiro Pacheco; Rodrigo Altenfelder Silva; André de Moricz; Tércio de Campos
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

2.  Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer.

Authors:  Emre Yekedüz; Ömer Dizdar; Neyran Kertmen; Sercan Aksoy
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

3.  Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes.

Authors:  Jonathan Pruessmann; Telja Pursche; Friederike Hammersen; Alexander Katalinic; Dorothea Fischer; Annika Waldmann
Journal:  Breast Care (Basel)       Date:  2020-05-13       Impact factor: 2.860

4.  Epidemiologic and clinicopathologic evaluation of patients with breast cancer referred to Ghaem Hospital from 2005 to 2014.

Authors:  S Kadkhodayan; F Homaee Shandiz
Journal:  J Med Life       Date:  2015

Review 5.  Metastatic and triple-negative breast cancer: challenges and treatment options.

Authors:  Sumayah Al-Mahmood; Justin Sapiezynski; Olga B Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

6.  Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.

Authors:  Li Chen; Ping Bai; Xiangyi Kong; Shaolong Huang; Zhongzhao Wang; Xiangyu Wang; Yi Fang; Jing Wang
Journal:  Front Cell Dev Biol       Date:  2021-03-30

7.  Axillary management for early invasive breast cancer patients: Who will truly benefit?

Authors:  Yanbiao Liu; Yan Fan; Zining Jin; Mengyao Cui; Xinmiao Yu; Feng Jin; Xu Wang
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.